Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study was conducted in compliance with OECD GLP regulations.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
MTDID 28136
IUPAC Name:
MTDID 28136
Test material form:
other: Gas
Details on test material:
- Name of test material (as cited in study report): MTDID 28136
- Substance type: Mono-constituent
- Physical state: Gas
- Analytical purity: 99.97
- Purity test date: 26 December 2013
- Lot/batch No.: Lot 2

Method

Target gene:
Salmonella thyphimurium strains: Histidine operon, Escherichia coli: thyptophan operon
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
Arclor 1254 induced rat liver S9 mix
Test concentrations with justification for top dose:
0.0781, 0.156, 0.313, 0.625, 1.25, 2.50, 5.00, 10.0, 20.0, and 40.0 % v/v
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Air
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: Strain Specific
Remarks:
TA100, TA1535, WP2 uvrA: Chloroethane, TA1537: ICR-191 acridine, TA98: 2-nitrofluorene
Details on test system and experimental conditions:
METHOD OF APPLICATION: Incubation in a bag containing the test article at the appropriate concentration.

DURATION
- Preincubation period: None
- Exposure duration: 2 days
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): NA
- Fixation time (start of exposure up to fixation or harvest of cells): 2 days

SELECTION AGENT (mutation assays): None

NUMBER OF CELLS EVALUATED: All

DETERMINATION OF CYTOTOXICITY
- Method: A concentration was considered cytotoxic if it caused a >50% reduction in the mean number of revertants per plate as compared to the mean vehicle control accompanied by an abrupt concentration-dependent drop in the mean number of revertants or a significant reduction in the background lawn
Evaluation criteria:
The test substance was considered positive for mutagenicity if it induced an increase of revertants per plate with increasing concentration. The increases should be at least two times the vehicle control substance background frequency for strains with high spontaneous levels (TA100) and three times for those with low spontaneous levels (TA1537, TA98, TA1535, and WP2 uvrA). Increases should be seen in at least two or more successive concentrations or the response should be repeatable at a single concentration.

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RANGE-FINDING/SCREENING STUDIES: A rangefinding assay was conducted at concentrations of 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3, 10 and 30% v/v. Cytotoxicity was observed at concentrations at and above 3% in TA100 with and without metabolic activation and WP2 uvrA with metabolic activation and at 10% or greater in WP2 uvrA without metabolic activation.

COMPARISON WITH HISTORICAL CONTROL DATA: Controls were consistent with historical data.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Based on the results of the test, the test article was not mutagenic in the Bacterial Reverse Mutation Assay in either the presence or absence of metabolic activation.
Executive summary:

The mutagenic potential of the test article was evaluated in the Bacterial Reverse Mutation Assay with S. typhimurium strains TA98, TA100, TA1535, and TA1537 and E. coli strain WP2 uvrA in the presence and absence of a metabolic activation system (S9-mix rat liver induced by Arclor 1254). The study was performed in compliance with OECD GLP. The test method was based on OECD No. 471 and ICH S2A and S2B.  Plates were exposed to the test substance via incubation in a sealed bag containing the test article at the appropriate concentration. Strains TA100, TA1535 and WP2 uvrA were exposed to chloroethane as a positive control. A dose range-finding test was performed with concentration up to 30% v/v test article in the absence and presence of metabolic activation in strains TA100 and WP2uvrA. Based on the results of the dose range finding test, the test article was tested at concentrations of 0 (control) 0.0781, 0.156, 0.313, 0.625, 1.25, 2.50, 5.00 and 10.0% v/v test article in TA1537 and TA100 with metabolic activation and at 10 % v/v in TA100 and WP2 uvrA without metabolic activation and TA1535 with and without metabolic activation. A confirmatory assay was performed at 0.0781, 0.156, 0.313, 0.625, 1.25, 2.50, 5.00, 10.0, 20.0, and 40.0 % v/v in strains TA98, TA1537 and WP2 uvrA. All treatments were performed in triplicate. No increase in revertant colonies was observed in either the presence or absence of metabolic activation in any strain tested. All criteria for a valid test were met as described in the protocol. Based on the results of the test, the test article was not mutagenic in the Bacterial Reverse Mutation Assay in either the presence or absence of metabolic activation.